Armata Pharmaceuticals (ARMP) Total Non-Current Liabilities (2013 - 2020)

Armata Pharmaceuticals has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $20.7 million for Q4 2020.

• Total Non-Current Liabilities for Q4 2020 came in at $20.7 million, up 117.21% year-over-year; the trailing twelve-month figure through Dec 2020 was $20.7 million (up 117.21% YoY), and the FY2020 annual result was $20.7 million, up 117.21% from the prior year.
• Total Non-Current Liabilities came in at $20.7 million for Q4 2020 at Armata Pharmaceuticals, up from $9.5 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $20.7 million in Q4 2020 to a low of $2.9 million in Q1 2018.
• The 5-year median for Total Non-Current Liabilities is $5.7 million (2018), against an average of $6.6 million.
• Across the five-year window, Total Non-Current Liabilities tumbled 76.66% in 2016 and surged 284.42% in 2019, its largest moves.
• Armata Pharmaceuticals' Total Non-Current Liabilities stood at $6.0 million in 2016, then slumped by 47.97% to $3.1 million in 2017, then surged by 84.08% to $5.7 million in 2018, then soared by 65.87% to $9.5 million in 2019, then soared by 117.21% to $20.7 million in 2020.
• The last three Total Non-Current Liabilities figures came in at $20.7 million (Q4 2020), $9.5 million (Q4 2019), and $9.9 million (Q3 2019), per Business Quant data.